EFPIA Newsletter 13 April 2023

Blog     13 April 2023 Supporting the Head and Neck Cancer Community April is Head & Neck Cancer Awareness Month, a chance for all of us to bring attention and resources to these deadly... Read more →

Join our team Senior Manager, Regulatory, Drug development & Manufacturing The Senior Manager Regulatory, Drug Development & Manufacturing coordinates activities related to regulatory and development topics, including development of policies and position papers, implementation of multi-stakeholder projects, interactions with regulatory authorities (European Medicines Agency, national regulators, European Commission) and support on regulatory matters to other teams at EFPIA. He/She reports to the Director Regulatory Strategy. For more information on the vacancy, please visit our dedicated page here.

Events     19 APR 2023   TOPRA Innovation Summit 2023 Amsterdam Innovation Driving Change Learn more →       24 APR 2023   Strengthening European health systems Online How to invest in innovation while driving efficiencies. Learn more →

	30 MAY 2023			Realising the potential of the European Health Data Space for Innovation Residence Palace, Rue de la Loi 155, 1040 Brussels EFPIA and COPAC are pleased to invite you to an in-person discussion on the key issues that are fundamental in ensuring... Learn more →

	22 JUN 2023			How the pharmaceutical industry is working to avoid and replace the use of animals... Zoom An online event co-organised by EFPIA and the RSPCA Learn more →

We published Enhancing patient centric outcome measures and clinical trials with digital health technologies... 13 April 2023 (Publications) Can digital technology really help to measure meaningful endpoints in clinical trials? Read more → Regulatory Road to Innovation Experts' Insights 22 March 2023 (Publications) How can we work together to create a world-class 21st century regulatory framework to deliver safer, better medicines... Read more →

What we are reading Sex, gender, and the cost of neurological disorders 01 May 2023  (The Lancet) Read more → Three things will enable society to thrive in the 21st century 12 April 2023  (LinkedIn) Read more → Eli Lilly warns EU will miss out on key drugs under planned change to patent rules 10 April 2023  (Financial Times) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe